Shivangi Harankhedkar: Gene Therapy and CRISPR Advances in Hemoglobinopathies
Shivangi Harankhedkar, Head Department of Molecular Diagnostics and Research IMS and SUM Hospital at Siksha ‘O’ Anusandhan University, shared a post on LinkedIn:
“It was a privilege to chair the session ‘Gene Therapy and CRISPR-Based Curative Approaches in Hemoglobinopathies’, delivered by Dr Debojyoti Chakraborty, Molecular Scientist, RNA Biology Lab at CSIR – Institute of Genomics and Integrative Biology, at the CME ‘Hemoglobinopathies 2026: Challenges, Care, Cure’, organised at AlIMS Bhubaneswar on the occasion of World Sickle Cell Day.
The session provided an insightful overview of how advances in gene addition and CRISPR-based genome editing are transforming the treatment landscape of sickle cell disease-from lifelong disease control towards the possibility of durable, potentially curative therapy.
The development of BIRSA-101, India’s first indigenous CRISPR-based gene therapy for sickle cell disease, represents a landmark initiative towards making advanced genomic therapies more relevant and accessible within our own healthcare setting.
India and particularly Odisha, with its significant burden of sickle cell disease-looks forward with great hope to its clinical development and successful translation into an affordable treatment for our patients.
Grateful to the organisers, happy that I could attend this encouraging and meaningful academic programme.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 15:45Alan Nurden: Could Mast Cell aIIb Integrin Play a Key Role in Septic Thrombus Stability?
-
Sep 29, 2026, 15:43Priyadarshani Sharma: Advocacy and Patient Rights Transform Indian Haemoglobinopathies Care
-
Sep 29, 2026, 15:21Kanchan K Banerjee: Rusfertide Earns NCCN Category 1 Recommendation for Polycythemia Vera
-
Sep 29, 2026, 15:06Faizan Khan։ The Worldwide Burden of Venous Thromboembolism
-
Sep 29, 2026, 14:59Global Von Willebrand Disease Diversity Webinar Now Available on EHC YouTube – EHC
-
Sep 29, 2026, 14:43Mary Cushman: Apply to Shape Scientific Publishing as ISTH Associate Editor
-
Sep 29, 2026, 14:32Honoring Women Leaders Advancing Research, Care, and Innovation in Thrombosis and Hemostasis – Seminars in Thrombosis and Hemostasis
-
Sep 29, 2026, 14:20Nathan Connell: Key Takeaways from the 8th Aland Island Meeting on von Willebrand Disease
-
Sep 29, 2026, 14:09Mariusz Ratajczak: Are We Inadvertently Destroying the True Regenerative Power of PRP by Discarding the Plasma?